Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Cooper

Showing results (341-350 of 399) with videos related to

Pageof 40
Sort By:
Clinical Science (London, England : 1979)|August 28, 2012
Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetesMona Sedeek, Alex Gutsol, Augusto C Montezano, et al.
Redox Biology|March 24, 2025
Proximal tubular deletion of superoxide dismutase-2 reveals disparate effects on kidney function in diabetesInez A Trambas, Lilliana Bowen, Vicki Thallas-Bonke, et al.
Cardiovascular Diabetology|November 20, 2024
Lipoxin A<sub>4</sub> improves cardiac remodeling and function in diabetes-associated cardiac dysfunctionTing Fu, Muthukumar Mohan, Madhura Bose, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 2015
Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular RemodelingStephen P Gray, Elyse Di Marco, Kit Kennedy, et al.
Diabetes|June 29, 2004
Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosisJosephine M Forbes, Louis Teo Loon Yee, Vicki Thallas, et al.
Diabetology International|March 25, 2020
Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established cardiovascular and/or kidney disease: subgroup analysis of the randomized CARMELINA<sup>®</sup> trialNobuya Inagaki, Wenying Yang, Hirotaka Watada, et al.
The American Journal of Clinical Nutrition|April 1, 2016
Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trialBarbora de Courten, Maximilian Pj de Courten, Georgia Soldatos, et al.
Journal of the American Society of Nephrology : JASN|February 11, 2014
Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathyJay C Jha, Stephen P Gray, David Barit, et al.
Journal of the American Society of Nephrology : JASN|January 23, 2009
RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetesMelinda T Coughlan, David R Thorburn, Sally A Penfold, et al.
Diabetologia|May 7, 2020
Empagliflozin modulates renal sympathetic and heart rate baroreflexes in a rabbit model of diabetesCindy Gueguen, Sandra L Burke, Benjamin Barzel, et al.
Pageof 40

Showing results (341-350 of 399) with videos related to

Sort By:
Pageof 40
Clinical Science (London, England : 1979)|August 28, 2012
Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetesMona Sedeek, Alex Gutsol, Augusto C Montezano, et al.
Redox Biology|March 24, 2025
Proximal tubular deletion of superoxide dismutase-2 reveals disparate effects on kidney function in diabetesInez A Trambas, Lilliana Bowen, Vicki Thallas-Bonke, et al.
Cardiovascular Diabetology|November 20, 2024
Lipoxin A<sub>4</sub> improves cardiac remodeling and function in diabetes-associated cardiac dysfunctionTing Fu, Muthukumar Mohan, Madhura Bose, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 2015
Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular RemodelingStephen P Gray, Elyse Di Marco, Kit Kennedy, et al.
Diabetes|June 29, 2004
Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosisJosephine M Forbes, Louis Teo Loon Yee, Vicki Thallas, et al.
Diabetology International|March 25, 2020
Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established cardiovascular and/or kidney disease: subgroup analysis of the randomized CARMELINA<sup>®</sup> trialNobuya Inagaki, Wenying Yang, Hirotaka Watada, et al.
The American Journal of Clinical Nutrition|April 1, 2016
Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trialBarbora de Courten, Maximilian Pj de Courten, Georgia Soldatos, et al.
Journal of the American Society of Nephrology : JASN|February 11, 2014
Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathyJay C Jha, Stephen P Gray, David Barit, et al.
Journal of the American Society of Nephrology : JASN|January 23, 2009
RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetesMelinda T Coughlan, David R Thorburn, Sally A Penfold, et al.
Diabetologia|May 7, 2020
Empagliflozin modulates renal sympathetic and heart rate baroreflexes in a rabbit model of diabetesCindy Gueguen, Sandra L Burke, Benjamin Barzel, et al.
Pageof 40